Phase I human study and preclinical evaluations of OcuRing™-K showed no treatment-related safety concerns, supporting ...

Bacterial Conjunctivitis Drugs Market is expected to reach US$ 4.9 Billion by 2036, Driven by Increasing Prevalence of Eye ...

AptarGroup, Inc. , a global leader in drug delivery and consumer product dosing, dispensing and protection technologies, announced that its innovative nasal vaccine delivery solutions, LuerVax® and ...

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutationsAdolore's Kv7 voltage-gated ...

The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...

Sanofi may rebid for Ocular Therapeutix, Inc. to boost retinal therapeutics ahead of Dupixent patent expiry. Click for more ...

Vetter, a globally operating CDMO, has completed several important steps in the ongoing development and upcoming launch of V-OVS® next.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

The recent update to Viatris centers on a refreshed US$16 price target, set against a fair value estimate that has inched from about US$12.44 to roughly US$12.67 as the affordable medicines theme ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

Objectives Outward medical tourism is when people seek medical treatment in a different country to the one they live in. We ...